MedPath

Clinical study of sensory evaluation using Olmesartan orally disintegrating tablet (OD tablets) for hypertensive patients.

Not Applicable
Conditions
Hypertension
Registration Number
JPRN-UMIN000019202
Lead Sponsor
Medical corporation Ishinkai Oda clinic
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients who are taking dementia therapeutics. 2) Patients who are a history of hypersensitivity to Olmesartan tablet. 3) Diabetic patients who are taking aliskiren fumarate(Except for uncontrolled patients of blood pressure by doing other antihypertensive treatment.) 4) Patients who are pregnant or during lactation, or there is becoming the possibility of pregnant. 5) Patients who jugged unsuitable for this study by the investigator.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of sensory
Secondary Outcome Measures
NameTimeMethod
Evaluation of safety
© Copyright 2025. All Rights Reserved by MedPath